Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05564949 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 31, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. 2 versions Re-verified since Jan 30, 2024, no change to tracked fieldsv2-v3
  2. Study First Submitted
Attikon Hospital
19 trials monitored
See all monitored trials
Glioma
1,251 trials monitored
See 88 trials at risk
The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.
Trial Details
NCT Number NCT05564949
Lead Sponsor Attikon Hospital
Conditions
(from sponsor)		 Brain, Cancer
Related terms Glioma, Neoplasm Metastasis, Neoplasms
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov